Genetic variation in the apolipoproteins C-II and C-III.

[1]  T. Ogura,et al.  Molecular cloning of a human apoC-III variant: Thr 74----Ala 74 mutation prevents O-glycosylation. , 1987, Journal of lipid research.

[2]  E. Boerwinkle,et al.  The use of measured genotype information in the analysis of quantitative phenotypes in man. , 1987, Annals of human genetics.

[3]  E. Ritman,et al.  Regional myocardial volume perfused by the coronary artery branch: estimation in vivo. , 1986, Circulation.

[4]  E. Boerwinkle,et al.  The use of measured genotype information in the analysis of quantitative phenotypes in man , 1986, Annals of human genetics.

[5]  R. Havel,et al.  A variant primary structure of apolipoprotein C-II in individuals of African descent. , 1986, The Journal of clinical investigation.

[6]  Roger A. Renfrew,et al.  Lipid Research Clinics Program. , 1984, JAMA.

[7]  R. Norum,et al.  Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease. , 1982, The New England journal of medicine.

[8]  J. Little,et al.  Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. , 1978, The New England journal of medicine.

[9]  Bhattacharya Cg.  A simple method of resolution of a distribution into gaussian components. , 1967 .

[10]  J. Heremans,et al.  Immunochemical quantitation of antigens by single radial immunodiffusion. , 1965, Immunochemistry.

[11]  J. Breslow.  Apolipoprotein genetic variation and human disease. , 1988, Physiological reviews.

[12]  R. Ferrell,et al.  Genetic studies of human apolipoproteins. III. Polymorphism of apolipoprotein C-II. , 1988, Human heredity.

[13]  R. Ferrell,et al.  Genetic studies of human apolipoproteins. II. A rapid one‐dimensional isoelectric focusing technique to characterize apolipoproteins A‐I, A‐II, A‐IV and C‐II of unfractionated plasma , 1987 .

[14]  C. Robert Cloninger,et al.  Apolipoprotein genetic variation in the assessment of atherosclerosis susceptibility , 1987, Genetic epidemiology.